Precipio (NASDAQ:PRPO – Get Free Report) and Clover Health Investments (NASDAQ:CLOV – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, analyst recommendations and profitability.
Valuation and Earnings
This table compares Precipio and Clover Health Investments”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Precipio | $18.53 million | 2.29 | -$4.29 million | ($0.82) | -29.63 |
| Clover Health Investments | $1.37 billion | 0.81 | -$43.01 million | ($0.11) | -19.55 |
Risk and Volatility
Precipio has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 2.09, meaning that its stock price is 109% more volatile than the S&P 500.
Analyst Ratings
This is a summary of recent ratings for Precipio and Clover Health Investments, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Precipio | 1 | 0 | 0 | 0 | 1.00 |
| Clover Health Investments | 1 | 3 | 1 | 0 | 2.00 |
Clover Health Investments has a consensus target price of $3.23, indicating a potential upside of 50.39%. Given Clover Health Investments’ stronger consensus rating and higher probable upside, analysts clearly believe Clover Health Investments is more favorable than Precipio.
Insider and Institutional Ownership
10.5% of Precipio shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 16.9% of Precipio shares are held by company insiders. Comparatively, 24.1% of Clover Health Investments shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Profitability
This table compares Precipio and Clover Health Investments’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Precipio | -5.50% | -10.07% | -6.71% |
| Clover Health Investments | -3.29% | -16.79% | -9.95% |
Summary
Clover Health Investments beats Precipio on 10 of the 14 factors compared between the two stocks.
About Precipio
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.
About Clover Health Investments
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.
